Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Moodys
UBS
Daiichi Sankyo
US Army
Express Scripts

Generated: August 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for SGI-110

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for SGI-110

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
SGI-110 ➤ Sign Up Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in ovarian cancer UNIVERSITY OF MARYLAND, BALTIMORE (Baltimore, MD) THE JOHNS HOPKINS UNIVERSITY (Baltimore, MD) ➤ Sign Up
SGI-110 ➤ Sign Up Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in lung cancer UNIVERSITY OF MARYLAND, BALTIMORE (Baltimore, MD) THE JOHNS HOPKINS UNIVERSITY (Baltimore, MD) ➤ Sign Up
SGI-110 ➤ Sign Up Histone deacetylase (HDAC) inhibitor up-regulates car expression and targeted antigen intensity, increasing antitumor efficacy Baylor College of Medicine (Houston, TX) ➤ Sign Up
SGI-110 ➤ Sign Up Methods, kits, and compositions for stem cell self-renewal STOWERS INSTITUTE FOR MEDICAL RESEARCH (Kansas City, MO) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for SGI-110

Drugname Country Document Number Estimated Expiration Related US Patent
SGI-110 European Patent Office 3102199 2034-01-21 ➤ Sign Up
SGI-110 World Intellectual Property Organization (WIPO) 2015112598 2034-01-21 ➤ Sign Up
SGI-110 European Patent Office 3102199 2034-01-21 ➤ Sign Up
SGI-110 World Intellectual Property Organization (WIPO) 2015112598 2034-01-21 ➤ Sign Up
SGI-110 European Patent Office 3021853 2033-07-18 ➤ Sign Up
SGI-110 Japan 2016525124 2033-07-18 ➤ Sign Up
SGI-110 World Intellectual Property Organization (WIPO) 2015010096 2033-07-18 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
AstraZeneca
Argus Health
UBS
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.